APPLICATION NOTE
Automated Expansion and AI-Driven Monitoring of Patient-Derived CRC Organoids Using the CellXpress.ai System
Automate expansion and AI-driven monitoring of patient-derived colorectal cancer (CRC) organoids for consistent, assay-ready cultures
Manual patient-derived CRC organoid culture is complex and time-intensive, requiring frequent monitoring and precise handling that can introduce variability. This application note shows how the CellXpress.ai® Automated Cell Culture System enables automated expansion and AI-driven monitoring of CRC organoids using integrated imaging and machine learning–based analysis to guide feeding and passaging decisions. By replacing subjective assessments with standardized, criteria-based workflows, labs can improve consistency, reduce manual intervention, and reliably generate assay-ready organoids for downstream applications. Explore how you can standardize CRC organoid workflows and generate reproducible, assay-ready cultures with AI-driven automation.
Thank you for your interest.
We’re excited to share with you our latest learnings – from new product innovations to improved methods for automating complex biology workflows – our experts look forward to connecting with you and exploring ways to advance scientific research, together.